Verdicts
May 6, 2008
Delay Is No Setback to Vioxx Deal, Parties Say
While Merck's decision to extend the deadline for claimants joining its proposed $4.85 billion Vioxx personal-injury settlement was met with some outside speculation the company was not meeting enrollment targets, both the drug maker and plaintiff's lawyers are calling the delay purely administrative.
Daily Journal Staff Writer
This article appears on Page 4
LOS ANGELES - While Merck's decision to extend the deadline for claimants joining its proposed $4.85 billion Vioxx personal-injury settlement was met with some outside speculation the company was not meeting enrollment targets, both the drug maker and plaintiff's lawyers are calling the delay purely administrative.
&nbs...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In